LabGenomics Co., Ltd. (KOSDAQ:084650)
South Korea · Delayed Price · Currency is KRW 1,638.00
-34.00 (-2.03%)
Feb 20, 2026, 3:30 PM KST
LabGenomics Market Cap
LabGenomics has a market cap or net worth of 121.61 billion as of February 20, 2026. Its market cap has decreased by -43.71% in one year.
Market Cap
121.61B
Enterprise Value
106.26B
Revenue
89.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,638.00
Market Cap Chart
Since December 16, 2014, LabGenomics's market cap has increased from 56.52B to 121.61B, an increase of 115.16%. That is a compound annual growth rate of 7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 121.61B | -9.55% |
| Dec 30, 2025 | 134.45B | -27.27% |
| Dec 30, 2024 | 184.86B | -35.41% |
| Dec 28, 2023 | 286.20B | 33.64% |
| Dec 29, 2022 | 214.15B | -23.76% |
| Dec 30, 2021 | 280.90B | 31.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 404.15B |
| DreamCIS | 141.81B |
| HLB bioStep | 106.69B |
| P&K Skin Research Center | 69.32B |
| C&R Research | 51.44B |
| WOOJUNG BIO | 40.48B |
| DT&CRO CO. | 35.28B |
| SLS BIO | 26.89B |